Skip to main content

Alzheimer & Parkinson

Exploring healthy aging through preclinical Alzheimer disease in the Knight Alzheimer Research Imaging dataset

1 day 7 hours ago
Alzheimer disease (AD) remains a significant global public health challenge, requiring robust multimodal datasets to elucidate its prolonged preclinical phase, improve early detection, advance understanding of disease trajectories, and guide intervention strategies. Here we present the Knight Alzheimer Research Imaging (KARI) dataset, established by the Washington University Knight ADRC to address this critical need. We detail comprehensive multimodal neuroimaging from 1,645 participants (aged...
David A Hoagey

Plasma eMTBR-tau243 and p-tau205 as T2 biomarkers for biological staging and prognosis in Alzheimer's disease

1 day 7 hours ago
Plasma biomarkers that reflect distinct stages of Alzheimer's disease (AD) could enable scalable biological staging. We evaluated phosphorylated tau (p-tau) species across multiple analytical platforms and the endogenously cleaved microtubule-binding region containing residue 243 (eMTBR-tau243) using a dedicated LC-MS/MS platform in a well-characterized cohort with amyloid PET and a subset with tau PET. While T1 biomarkers increased during preclinical stages, eMTBR-tau243 and p-tau205 increased...
Sohyun Yim

Early menopause is associated with reduced global brain activity

1 day 7 hours ago
Menopause affects the aging process in women through a significant decline in ovarian hormone production in midlife. Women who experience early menopause show accelerated physiological aging, poorer memory, and increased risk of neurodegenerative diseases. However, how menopause timing affects brain activity remains unclear, which could be crucial for understanding early menopause-related aging acceleration and increased risk of dementia. Recent studies have revealed a highly structured...
Xufu Liu

Theta: a multivariate normative statistic applied to amyloid beta panel data in familial Alzheimer's disease

1 day 7 hours ago
Biomarker ratios often outperform individual biomarkers in complex, multifactorial diseases. In Alzheimer's disease, bivariate ratios may fail to capture the complex stoichiometry of amyloid β (Aβ) processing. We extended the ratio concept into a multivariate framework and performed experiments on Aβ peptide data from four familial Alzheimer's disease cohorts (8 controls, 223 PSEN1 mutation carriers). We define "theta" as a multivariate statistic quantifying the angular divergence of each...
Isaac Llorente-Saguer

Comparing plasma p-tau217 and plasma p-tau217/Abeta(42) with CSF biomarkers for assessing Alzheimer's disease pathology

1 day 7 hours ago
Plasma biomarkers for Alzheimer's disease (AD) on fully automated platforms offer accessible, cost-effective diagnostic tools. Here we aimed to compare Lumipulse plasma phospho-tau217 (p-tau217) and the p-tau217/beta-amyloid42 ratio (p-tau217/Aβ(42)) with regulatory-authorized cerebrospinal fluid (CSF) biomarkers (Aβ(42)/Aβ(40) and p-tau181/Aβ(42)) for identifying AD pathology (Aβ-PET visual read) across a memory clinic (n = 129), a primary care (n = 220) and a research cohort (n = 165)....
Noëlle Warmenhoven

Hypothalamic volume and cell-type changes in ageing and Alzheimer's disease

1 day 7 hours ago
Alterations in metabolism, stress response, sleep, circadian rhythms and neuroendocrine processes are key features of ageing and neurodegeneration^(1,2). These fundamental processes are regulated by the hypothalamus, yet how its functionally distinct subregions and cell types change during human ageing and Alzheimer's disease (AD) remains largely unexplored. Here we present HypoAD, an atlas of the human hypothalamus in ageing and AD, including high-resolution magnetic resonance imaging from 458...
Doudou Yu

Epigenetic control of neural homeostasis by REST

1 day 7 hours ago
Neural network stability relies on homeostatic plasticity mechanisms acting across intrinsic, synaptic, and glial levels to counter persistent deviations in activity. In hyperexcitable or chronically stressed brain states, including epilepsy, neuroinflammation, ageing, and early Alzheimer's disease, sustained stress can destabilize these compensatory programs and network function. Alongside its established roles in neuronal differentiation and neurological disease when dysregulated, repressor...
Pietro Baldelli

Galectin-3 links microglial neuroinflammation to Aβ aggregation and lysosomal processing

1 day 7 hours ago
Neuroinflammation is a hallmark of Alzheimer's disease (AD), yet the molecular mechanisms linking microglial dysfunction to amyloid-β (Aβ) pathology remain incompletely understood. Here, we identify galectin-3 (Gal3) as a regulator of plaque-associated microglial responses, linking Aβ aggregation, lysosomal function, and neuritic pathology. Using postmortem brain tissue from AD patients, we found that Gal3^(+) microglia preferentially associate with cored plaques and correlate with increased...
Lluís Camprubí-Ferrer

Structural basis for the selective inhibition of the PI3KC3-C2 complex by Rubicon in endolysosome maturation and mitophagy

1 day 7 hours ago
Rubicon is a negative regulator of autophagy and the endolysosomal network (ELN) and an antagonist of the class III phosphatidylinositol 3-kinase complex II (PI3KC3-C2). Inhibition of Rubicon is considered a potential means to therapeutically upregulate autophagy and the ELN to treat Parkinson's disease and other conditions characterized by autophagic and ELN dysfunction. Rubicon is specific for the UV radiation resistance-associated gene protein (UVRAG)-containing PI3KC3-C2 over the purely...
Minghao Chen

Computational identification of amyloid-mimicking microbial peptides with predicted MHC-II presentation relevance to Alzheimer's disease

2 days 7 hours ago
Accumulating evidence suggests a link between gut microbiota, host immunity, and Alzheimer's disease (AD), while specific MHC-II alleles have been associated with disease susceptibility or protection. Here, we applied a computational framework to investigate whether microbial proteins contain amyloid-like motifs capable of interacting with Aβ42 and whether such peptides are differentially presented by distinct MHC-II alleles. We identified an aggregation-prone core within Aβ42 and screened...
Weichen Gong

Early DNA repair and stress response signatures in prodromal Parkinson's disease

2 days 7 hours ago
Parkinson’s disease begins years before motor symptoms appear. Longitudinal blood transcriptomics shows that DNA repair and stress response pathways are most altered during this prodromal phase, then lose discriminative power in established disease. In this Comment, we link these changes to aging-related DNA damage and consider their biomarker potential. Mirroring aging hallmarks, they suggest a prodromal intervention window, when mechanisms driving dopaminergic neuron vulnerability are most...
Nicola Pietro Montaldo

A cell-type-resolved proteomic atlas reveals intra- and intercellular signaling in Alzheimer's disease

2 days 7 hours ago
Alzheimer's disease (AD) arises from pathological interactions among diverse brain cell types, but cell-type-specific proteomic changes remain underexplored. Here, we present deep proteomic profiling of sorted or proximity-labeled brain cells from AD mouse models (5xFAD and App^(NL-G-F)) at multiple ages, quantifying 13,411 proteins in microglia, astrocytes, oligodendrocyte precursor cells, and neurons, with additional spatial information. We identified 3,028 differentially abundant proteins,...
Xue Zhang

Brain border-associated macrophages rhythmically scavenge amyloid-beta and regulate vascular amyloid pathology

2 days 7 hours ago
Circadian disruptions perturb the brain and immune system and increase the risk of developing Alzheimer's disease (AD), yet whether this involves dysregulation of brain immunity remains less clear. Here, we performed single-cell RNA sequencing of the brain immune compartment around the day-night cycle and identified brain border-associated macrophages (BAMs) as highly rhythmic cells. We found that the rest phase was a specialized time for BAM engulfment, characterized by upregulation of...
Helena J Barr

Intranasal delivery of a ROS-activatable myeloperoxidase inhibitor alleviates Alzheimer's-like symptoms and pathology

2 days 7 hours ago
Chronic neuroinflammation and oxidative stress are important contributors to Alzheimer's disease (AD). Myeloperoxidase (MPO), a key driver of oxidative inflammation released mainly by activated microglia in the neurodegenerative brain, is a potential therapeutic target to inhibit the neuroinflammatory cascade and oxidative damage in AD, but the underlying mechanisms remain unexplored, and achieving targeted brain delivery of an MPO inhibitor and minimizing systemic effects remain significant...
Jing Wang

APOE epsilon4 carriership status enhances age-related changes in Alzheimer's disease plasma biomarkers concentrations

3 days 7 hours ago
Alzheimer's disease (AD) plasma biomarkers are cost-effective tools to detect early stage amyloid pathology. We investigated how interactions between AD genetic risk (apolipoprotein E (APOE) ε4, AD polygenic risk score (excluding APOE; PRS(AD))), age, and sex affected AD plasma biomarkers concentrations in a population-based cohort. We included 5913 participants from the Netherlands Twin Register age 30 - 80 (64.1% females, 29.8% ε4 carriers) and measured plasma phosphorylated-tau-217...
Rebecca Z Rousset

An open agentic AI co-scientist for clinical and biomedical discovery

3 days 7 hours ago
Biomedical research is constrained by the time and domain expertise required to analyze increasingly large and complex datasets. Here we present OpenScientist, an open-source agentic AI co-scientist designed to address this gap by investigating scientist-defined queries and generating verifiable, data-grounded analyses. OpenScientist was evaluated by domain experts across five biomedical case studies, completing analyses in minutes that otherwise would take months of human time and expertise. It...
Kaleigh F Roberts

CD22 loss enhances phagocytosis in myeloid cells and ameliorates Alzheimer's disease-like pathology in mice

4 days 7 hours ago
CD22, an inhibitory receptor canonically expressed in B cells, is also present in microglia of the murine central nervous system. In the human brain, CD22 was predominantly found in oligodendrocytes, but also in a subset of brain-resident myeloid cells from patients with Alzheimer's disease, while it is also expressed in peripheral monocytes and differentiated THP-1 cells. CD22 has been implicated as a negative regulator of microglial phagocytosis. Here, we demonstrate that genetic ablation of...
Veroniqué Tschui

Thickness of the peripapillary retinal nerve fiber layer and its association with disease severity in Parkinson's disease: a cross-sectional case-control study

4 days 7 hours ago
Peripapillary retinal nerve fiber layer (pRNFL) alterations are linked to retinal neurodegeneration in Parkinson's disease (PD), but their regional pattern and clinical relevance remain unclear. This cross-sectional case-control study included 63 PD patients (123 eyes; Hoehn-Yahr [H-Y] stages 1.0-2.5: 47; stages 3-5: 16) and 16 healthy controls (32 eyes). Swept-source optical coherence tomography measured average and quadrant-specific pRNFL thickness. Generalized estimating equations accounted...
Jianglong Li
Checked
26 minutes 4 seconds ago
Alzheimer and Parkinson: Latest results from PubMed
Subscribe to Alzheimer & Parkinson feed